<DOC>
	<DOCNO>NCT01536158</DOCNO>
	<brief_summary>The purpose study determine whether oral paracetamol ibuprofen well efficacy tolerance closure patent ductus arteriosus preterm infant .</brief_summary>
	<brief_title>Oral Paracetamol Versus Oral Ibuprofen Management Patent Ductus Arteriosus Preterm Infants : A Randomised Controlled Trial</brief_title>
	<detailed_description>To determine whether oral paracetamol ibuprofen well efficacy tolerance closure patent ductus arteriosus preterm infant . Eighty preterm infant patent ductus arteriosus enrol prospective-randomized study . Patients receive oral ibuprofen initial dose 10 mg/kg , follow 5 mg/kg 24 48 h oral paracetamol 15 mg/kg per dose every 6 hour . One follow echocardiographic criterion duct size &gt; 1.5 mm , leave atrium-to-aorta ratio &gt; 1.5 , left-to-right shunting blood , end diastolic reversal blood flow aorta , poor cardiac function addition sign patent ductus arteriosis determine need treatment .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Birth weight 1250 gram Diagnosed patent ductus arteriosus Echocardiographic examination Accompanied congenital cardiac anomaly Urine output le 1 ml/kg/h precede 8 h , Serum creatinine level &gt; 1.6 mg/dl , Platelet count &lt; 60,000/mm3 , Liver failure , Hyperbilirubinemia require exchange transfusion Severe intracranial bleeding ( Grade III IV ) Intestinal abnormality necrotising enterocolitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Days</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Patent Ductus Arteriosus</keyword>
	<keyword>Paracetamol</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>Preterm infant</keyword>
</DOC>